Inflation blinked. The Fed gets a month off.
Cooling-but-3.4% is not 2% — it’s permission for the Fed to wait, not for portfolios to relax. Action: the bill ladder keeps earning while the committee argues; the week’s real income news is the TIPS story below.
Three trillion dollars is sitting in cash. Wall Street just bought the candy store.
Retail money-market funds hold a record $3 trillion earning about 3.5%, and advisers can’t pry it loose. So the industry went shopping: Goldman is paying up to $2.25 billion for NEOS, the “boomer candy” shop whose options-income ETFs pay 12% distributions — a $180 billion category growing 70% a year.
Scared money is a market, and Wall Street just priced it. Our answer is duller and cheaper: a bill ladder for the cash, coverage-tested dividends for the income, and no 12% distribution without asking where the 12% comes from.
Anthropic is shopping the largest IPO in history. The timing is the story.
The $965 billion AI company is courting investors for a fall listing on a $47 billion revenue run-rate — the same week the papers carry AI-bubble jitters, a “violent correction” warning, and healthcare quietly trading as the market’s anti-AI hedge.
IPOs price at the seller’s favorite moment — that’s the whole genre. We’ll read the filing the way we read SpaceX’s: with admiration, arithmetic, and no order ticket.
Wall Street wants to turn Nvidia chips into an asset class. What could go wrong?
A $500 billion plan: funds buy chips, lease them to AI companies, and Nvidia backstops up to 25% of the residual value. Broadcom already disclosed $29 billion of exposure on one Anthropic lease package. Skeptics have a name for the vendor financing its own demand: circularity lite. Meanwhile CoreWeave’s backlog hit $104 billion and the stock jumped 13%.
When the product finances the customer who buys the product, the cycle works until it doesn’t. We own the toll booths’ earnings, not their paper — and the AI bond flood stays an AVOID.
The oil squeeze moved downstream. Refiners are the whole story now.
The crack spread — refining’s profit margin — blew past $70 a barrel against a normal teens, as Iran’s exports hit near zero, Ukrainian drones cut Russian refining to a 20-year low, and California’s statewide average hit $5.60. Phillips 66 and Kinder Morgan (KMI) answered with a $5 billion, 900-mile pipeline to rescue the state that closed a fifth of its refining capacity.
The energy sleeve was built for exactly this shape of week: the toll collectors — refiners, pipelines, integrated majors — get paid on the squeeze whichever way crude wanders. CVX, XOM, WMB all REINFORCED.
Healthcare has become an AI short in disguise. Heard did the math.
Chip stocks and healthcare stocks now move in opposite directions — quant money treats the sector as the natural hedge on a market that’s become a single AI wager. Healthcare trades at 18 times earnings against the chips’ 22 to 30, and in the 2022 bear market and again in the recent AI jitters it beat semis by 30 points.
The portfolio’s healthcare sleeve just acquired a second job: it’s a hedge now, not only a holding. Own the growers — LLY, JNJ, UNH — and mind the patent cliffs; cheap isn’t the same as safe.
The power-stock party met the permitting office.
Constellation is down 23% this year, NRG 25%, Vistra 10% — while the equipment makers they were supposed to outshine ripped: GE Vernova up 55%, Caterpillar 47%. Texas froze data-center hookups for an election-year audit, and PJM’s new rules tilt toward building new power, not paying more for old plants.
Our Texas-audit watch from last week is aging well — and the lesson generalizes: in a build-out, own what gets bought, not what gets regulated. CAT stays reinforced; the merchant power names stay on WATCH.
France holds a marathon with twenty wine stops. It sells out in nine minutes.
The Marathon du Medoc runs 26.2 miles through Bordeaux with wine, oysters, cheese and steak along the route. Dietitians object. The runners — average age north of 40 — do not. The race president insists the point is to “taste the wines like professionals.”
Somewhere between the optimizers and the abstainers is a Frenchman jogging past a chateau with a plastic cup, living to 90 out of spite. The plan should fund that guy.
The best longevity drug this week is your grandchildren.
A geriatric psychiatrist’s roundup: strong purpose cuts mortality risk in one study by 46%, positive beliefs about aging add 7.5 years, and involved grandparenting improves mobility, mood and memory. The fine print: full-time custodial care without support reverses the benefit. Involvement, not duty.
Purpose is the asset the statement can’t show. Planning translation: fund proximity — the flights, the spare bedroom, the school-pickup schedule. It compounds better than most tickers.
The quiet income deal of the decade: 3% real, guaranteed, for 30 years.
Long-dated TIPS now pay nearly 3% above inflation — the best in decades — while stocks’ inflation-adjusted earnings yield sits near its lowest ever. Heard’s verdict: as close to long-term peace of mind as investing gets. The catch is a tax quirk: hold them in the IRA, not the taxable account.
This one goes in the portfolio, not just the paper: a starter LTPZ position joins the income sleeve, tax-deferred accounts only. The bill ladder handles today; TIPS now handle the next thirty years.
Your condo fee is going up. This time it’s the mortgage giants asking.
Fannie and Freddie now want associations reserving at least 15% of dues — and only 39% of buildings qualify today. Median dues already hit $420 a month, up 29% since 2019. The post-Surfside math is finally arriving in everyone’s mailbox.
Same file as last week’s HOA foreclosure story: the reserve study is now a document we read before you buy, and annually after. Underfunded buildings are deferred assessments wearing a lobby.
They feed every heartbeat to an AI. The AI identified the stressful coworker.
The datamaxxers pipe sleep, heart-rate and calendar data into chatbot dashboards as hyper-personal coaches — one engineer’s model fingered which colleague spiked his pulse (“Claude said this guy is the prime suspect”). Doctors’ caveat: the dashboards are great at trends, hazardous at diagnoses.
A third of adults now ask AI about their health, so the house rule: bring the dashboard to the doctor, not instead of the doctor. Same rule we use for portfolios, coincidentally.
Two families. Twelve events. The grand prize: a last name.
The Flemings and the Schifferles settled whose surname the kids would carry with a five-hour backyard Olympics — Jenga, charades, a dance battle, a three-minute plank — decided, in the end, by rock-paper-scissors. Roughly 80% of American women still take a spouse’s name; these two families took the scenic route.
No financial angle. A governance lesson, maybe: the best family decisions get a process everyone can live with. We’ve seen estate plans settled with less grace than a wheelbarrow race.